Combining CD64 and CD123 Biomarkers for Sepsis Early Diagnosis and Severity Assessment via PD-L1 Antibody Affinity Microfluidic (PAAM) Chip in Trace Clinical Samples

Post time 1 hour(s) ago

journal：Analytical Chemistry

Authors：Haoni Yan; Yan Zhang; Yujie Shi; Jiahui Ding; Hengxing Su; Wenqiong Su; Yan Wang; Yanfei Mao; Tawfik A. Khattab; Salhah D. Al-Qahtani; Aynur Abdulla; Lai Jiang; Xianting Ding

Published date：2025-4-15

DOI：10.1021/acs.analchem.4c07123

PDF link：https://pubs.acs.org/doi/pdf/10.1021/acs.analchem.4c07123

Article link：https://doi.org/10.1021/acs.analchem.4c07123

Article Source：American Chemical Society (ACS)。

Remark：

Post time Half hour(s) ago

: Waiting for confirmation
If the PDF has not been accepted after 72 hours, the system will automatically adopt it.

[ACS] Combining CD64 and CD123 Biomarkers for Sepsis Early Diagnosis and Severity Assessment via PD-L1 Antibody Affinity Microfluidic (PAAM) Chip in Trace Clinical Samples

Same Category

Latest Reply

Announcement

Daily Top Contributors

[ACS] Combining CD64 and CD123 Biomarkers for Sepsis Early Diagnosis and Severity Assessment via PD-L1 Antibody Affinity Microfluidic (PAAM) Chip in Trace Clinical Samples Copy

Same Category

Latest Reply

Announcement

Daily Top Contributors

[ACS] Combining CD64 and CD123 Biomarkers for Sepsis Early Diagnosis and Severity Assessment via PD-L1 Antibody Affinity Microfluidic (PAAM) Chip in Trace Clinical Samples